News
US President Trump has signed executive orders to speed up drug approvals and pharma infrastructure construction in the US ...
Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results